Search for:
Search for:
Healthcare Professionals
Publications
Contact
News
Español
Magazine
Radio
INFÓRMESE
¿Qué es EM?
Un trastorno neurológico crónico que afecta el sistema nervioso central, compuesto por el cerebro...
Más detalles
MATERIALES EDUCATIVOS
PREGUNTAS COMUNES
Lending Library
Symptoms
Treatment Options
Additional Resources
INVESTIGACIÓN
MS Awareness Month
DONAR
OBTENGA AYUDA
Programa de Salud y Bi...
Obtenga materiales educativos y referencias así como también la oportunidad de participar en...
Más información
Grants & Programs
Awareness Campaigns
GRUPOS DE APOYO
Events
Lending Library
Additional Resources
PARTICIPE
Mes de Concientización...
Una campaña anual a nivel nacional con objetivos para promover la comprensión de la EM y ayudar a...
Más información
Advocacy
COMPRAS A SOCIOS
VOLUNTARIO
Businesses
MS Research Trials
Outreach
Supporter Program
Awareness Campaigns
Host an Event
Events
Test Flyout
lorem ipsum dolor sit lorem ipsum dolor sit lorem ipsum dolor sit lorem ipsum dolor sit lorem...
Learn More
Events Calendar
Health & Wellness
Fundraisers
Support
Web & Teleconferences
MS Education
Host an Event
QUIÉNES SOMOS
Programas y Subvenciones
Más detalles
Overview
Press Room
LIDERAZGO
ESTADOS FINANCIEROS
NUESTRA MISIÓN
Careers at MS Focus
Affiliations
News
PROGRAMA DE COMPUTADORA
El programa informático de MS Focus proporciona computadoras portátiles o de escritorio para...
/Get-Help/MSF-Programs-Grants/Computer-Program
Shop
Privacy
Terms of Use
Site Map
Monkeypox vaccine and MS
agosto 15, 2022
Since the first case was reported in the U.S. on May 18, the threat of monkeypox has escalated several thousands of cases. According to the CDC, as of Aug. 11, there were a total of 10,768 confirmed cases of monkeypox in the U.S. As a consequence, getting the vaccine has become an important issue for the MS community.
There are two Monkeypox vaccines: Jynneos and ACAM2000. Jynneos, is a nonreplicating live vaccine and is felt to be safe for all, regardless of immune status. According to Dr. Ben Thrower, MS Focus senior medical advisor, “the ACAM2000 is a repurposed smallpox vaccine. It is a live virus and should not be given to anyone with a potentially compromised immune system. This would include people with MS in B cell therapies, S1P modulators, Mavenclad or Lemtrada.”
While not related to chickenpox, monkeypox is a rare disease caused by infection with the monkeypox virus. Symptoms are similar to those of smallpox but milder, and monkeypox is rarely fatal. The virus can spread from person to person through direct contact with the infectious rash, scabs, or body fluids. It also can be spread by respiratory secretions during prolonged, face-to-face contact, or during intimate physical contact, such as kissing, cuddling, or sex. The virus has also been shown to be able to spread through indirect contact from contaminated objects or materials.
Monkeypox symptoms include a rash that may be located on or near the genitals (penis, testicles, labia, and vagina) or anus and could be on other areas such as hands, feet, chest, face, or mouth. The rash will go through several stages, including scabs, before healing. The rash can initially look like pimples or blisters and may be painful or itchy.
Monkeypox typically lasts two to four weeks. Symptoms usually start within three weeks of exposure to the virus. If someone has flulike symptoms, they will usually develop a rash one to four days later. Monkeypox can be spread from the time symptoms start until the rash has healed, all scabs have fallen off, and a fresh layer of skin has formed.
For more information,
click here
.
[Error loading the control 'FeaturedNews', check event log for more details]